Dravet syndrome Archives - Cannabis News Box

GW Pharmaceuticals gains approval from European Commission for EPIDYOLEX®

EPIDYOLEX was approved in the EU after four randomized and controlled Phase 3 trials had been conducted

Bethan Rose Jenkins, Cannabis News Writer/Editorial • October 2, 2019

British drugs company GW Pharmaceuticals celebrated approval for its cannabinoid-based epilepsy medicine EPIDYOLEX® back in June 2018 in the United States. Now, EPIDYOLEX has also gained approval...

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial • May 3, 2018

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment...

Clinical trial shows cannabis extract reduces seizures in kids with rare disorder

May 25, 2017

Patients with a rare and debilitating form of epilepsy called Dravet syndrome have experienced a significant reduction in seizures after being treated with cannabis. In some cases, patients' seizures were...